中药单味药治疗类风湿关节炎研究进展  

Progress of Mon-Chinese Materia Medica in Treating Rheumatoid Arthritis

作　　者：杨丹丹[1,2] 张杰[2] 

机构地区：[1]辽宁中医药大学,辽宁沈阳110847 [2]中国医科大学附属第一医院,辽宁沈阳110001

出　　处：《辽宁中医药大学学报》2017年第10期53-55,共3页Journal of Liaoning University of Traditional Chinese Medicine

基　　金：国家重点基础研究发展计划(973计划)项目(2013CB531704);辽宁省自然科学基金课题(201202262);辽宁省名老中医工作室建设项目(辽卫函[2016]78号)

摘　　要：类风湿关节炎是一种全身性、自身免疫性疾病,是国际公认的重大难治性疾病,现代医学至今尚未研制出特效药物。西医常用非甾体类抗炎药、改善病情的抗风湿药、糖皮质激素、生物制剂等,均有较大的不良反应。而近年来中药以其毒副作用小、治疗疗效可靠的优势,在治疗类风湿关节炎中越来越受到关注。该文以雷公藤、白芍、青风藤为例,阐述中药单味药治疗类风湿关节炎的研究进展,为以后的临床研究提供理论依据。Rheumatoid arthritis is considered as a systemic,autoimmune disease. It is also recognized as an internationally refractory disease. Modern medicine has not developed specific pharmaceuticals. Western medicine commonly use NSAIDs,DMARDs,glucocorticoids,biologics. But they apparent greater side effects. In recent years,more attention was paid on traditional Chinese medicine to cure RA because of its less toxic side effects and advantages of reliable therapeutic effects. This paper takes Tripterygium wilfordii,Radix Paeoniae alba,Sinomenine for examples to illustrate the recent progress in the thearpy of RA. It is hoped that better theoretical basis can be provided for the further study of clinical researches.

关 键 词：类风湿关节炎 中药治疗 雷公藤 白芍 青风藤 

分 类 号：R593.22[医药卫生—内科学]